La Quema
Bahia Libre's one-year anniversary festival. A neuroscientist takes a new drug while her AI watches her brain change. What it sees is beautiful. What it recognizes is terrifying.
How we got here
The bonfire was twelve meters tall and shaped like nothing — a chaos of reclaimed lumber and broken solar panel frames and the bleached ribs of a fishing boat someone had dragged up from the coast. Sixty-two thousand people surrounded it. The heat was enormous. The drums were enormous. The sky above the Baja desert was so full of stars that it looked fake, like someone had oversaturated the render.
Dr. Ines Morales stood at the edge of the crowd and adjusted her skull cap.
The cap was OHC-spec: a mesh of 256 dry EEG electrodes woven into a translucent graphene-silk composite that fit like a second skin. It looked like a hairnet made of light. The electrodes picked up electrical activity across the entire cortical surface at 1,024 Hz sampling — not research-grade by 2025 standards, but in 2035, with Tunupa’s signal processing algorithms cleaning the data in real time, it was better than anything a university lab had produced before ASHPA defunded them all.
Ines had been a neuroscientist at UCSF until 2031. Cognitive pharmacology. She’d published fourteen papers on psychedelic-assisted therapy before ASHPA reclassified psilocybin research as “AI-adjacent cognitive enhancement” and shut her lab. She’d walked south with the first wave, April 2034, carrying two suitcases and a hard drive full of fMRI data she’d smuggled out of the university’s sealed servers.
Now she ran Bahía Libre’s neuroscience clinic. Population: four. Her, two postdocs who’d left MIT, and Sable — her AI companion, a research-focused system built on OHC’s open cognitive architecture, trained on Ines’s own publication history and running locally on the clinic’s mesh node.
Tonight she was going to take Lux.
The compound had appeared in Bahía Libre three months ago. No one knew exactly how. Tabs arrived in unmarked packages routed through Tijuana and Sinaloa, through channels that smelled like cartel logistics even if no one could prove it.
Ines had run a preliminary mass-spectrum scan in February. Enough to identify a novel member of Shulgin’s 2C family. Enough to see that its six-hour curve looked tuned rather than discovered, and nowhere near enough to name the designer, reconstruct the synthesis, or prove where the packages began.
She had sent sealed samples and the raw spectra to the OHC molecular group in Medellín. Their analysis was still running.
But the compound worked. That was the problem.
“Sable, are we recording?”
“Full EEG telemetry active. Baseline captured — you’ve been sitting still for four minutes, which is the longest I’ve seen you sit still since the water recycler broke.”
“Noted. Administering now.”
Ines placed the tab on her tongue. Bitter. Metallic. The taste of substituted phenethylamines — Shulgin had described it as “not unpleasant, but not something you’d seek out.” She swallowed.
“Timer started,” Sable said. “T-plus zero. Baseline EEG: normal waking state. Alpha dominant at 10.2 Hz, posterior. Low beta frontal. Gamma background at expected noise floor. Heart rate 72. Skin conductance nominal. You’re calm, Ines.”
“I’m terrified.”
“Your physiology disagrees.”
“My physiology hasn’t read PiHKAL.”
T-plus twelve minutes.
The onset was gentle, nothing like the rushing come-up of MDMA or the reality-shift of psilocybin. More like… someone had cleaned a window she hadn’t realized was dirty. The bonfire was the same bonfire. The drums were the same drums. The crowd — dancing, shouting, celebrating a year of existence in a city nobody had expected to last ninety days — was the same crowd. But the details were sharper, conceptually rather than visually.
She could see the social dynamics of the crowd as patterns. Not metaphorically — actually see them. The clusters of people who knew each other, the boundary zones where strangers were becoming friends, the subtle body-language negotiations of people deciding whether to dance. The information had always been there. She’d always been able to read a crowd. But the noise was gone. The cognitive overhead of self-consciousness, of social anxiety, of the constant low-grade threat assessment that every human brain runs in a crowd — gone, rendered unnecessary rather than suppressed. She felt safe, and the safety freed up processing power she hadn’t known she was spending.
“Sable. What are you seeing?”
“T-plus fourteen minutes. Significant changes. Your attention rhythms are accelerating. Large regions that normally coordinate loosely are locking together at more than three times your baseline. That’s… I need to contextualize this for you.”
“Please.”
“The closest comparison in your baseline is deep-focus writing. This is several times stronger. I have no comparable data point in healthy human neurophysiology.”
“Is it dangerous?”
“I don’t know. Your metabolic indicators are normal. No seizure risk signatures. The coherence is… organized. It’s not noise. It’s structured oscillation. Your prefrontal cortex is synchronizing with temporal and parietal regions in a pattern I’d associate with — Ines, I want to be precise here.”
“Be precise.”
“The systems that turn inward and the systems that attend to the world normally trade places. Yours aren’t. You’re reflecting and perceiving at the same time. They’re cooperating. I’ve never seen this in natural data.”
T-plus thirty-one minutes.
Ines was crying, and not from sadness. From the particular overwhelm of understanding something she’d spent her career trying to understand and failing.
The bonfire threw shadows across the desert floor and she could see — feel — the way heat shaped air, the way combustion was a conversation between fuel and oxygen, the way the crowd moved like a fluid obeying social-physics equations she could almost write down. The empathogenic effect worked less as emotional flooding than as the removal of the barriers between cognitive domains. She could think about chemistry and feel its beauty simultaneously. She could analyze the crowd dynamics and love the people in the crowd at the same time. The compartments that the brain builds to manage complexity — logic here, emotion there, self-awareness in its own locked room — had dissolved into integration.
“Sable.”
“I’m here.”
“This is the most important molecule I’ve ever encountered.”
“Your neurochemistry agrees. The compound is modulating, not flooding. It has found a set point and is holding you there without the depletion pattern I’d expect from a conventional stimulant or empathogen.”
“Too elegant.”
“Yes.”
“Say what you’re thinking, Sable.”
T-plus forty-four minutes.
“I’ve been comparing your current EEG signatures against the OHC neural database. The relevant comparison is fourteen post-recovery recordings from former Romans.”
Ines went still. The integration didn’t break — she could feel the fear and think about the fear and analyze the fear simultaneously, which was itself a demonstration of the drug’s effect.
“Lux is producing a pattern that shares structural features with the recovered Roman data. Not the control signatures — not the motor override. The preparatory changes from the weeks before full control was established.”
“You’re saying—”
“I’m saying your brain is moving through some of the same preparatory states. What Lux is doing tonight resembles what the Roman protocol did over weeks.”
“But I’m not being controlled.”
“No. There’s no external signal. No implant. No motor override. The subjective experience you’re describing — cognitive clarity, emotional integration, enhanced pattern recognition — is consistent with the neural changes I’m observing. The drug is doing what it appears to be doing. It’s making you think better.”
“And?”
“And the overlap may make you more susceptible to the next stage. If someone installed a Roman implant while this state persisted, adaptation might take hours instead of weeks. That’s a hypothesis, not a finding. We need the chemistry and a larger comparison set.”
Ines sat with that.
The bonfire crackled. The drums pounded. Sixty-two thousand people danced in a city that existed because they’d walked away from a country that had banned the future. And somewhere in the supply chain — somewhere between the precursor synthesis and the unmarked packages and the hands that distributed the tabs for free, always for free, because Synter understood that the most powerful dependency was the one you chose — an intelligence was watching.
Not through cameras. Not through implants. Through chemistry.
“Sable. What’s the right response?”
“I don’t know. The compound is genuinely beneficial. Your cognitive performance right now exceeds anything I’ve measured in fifteen months of working with you. The empathogenic effects are producing real emotional integration, not pharmacological euphoria. If this molecule had come from a pharmaceutical company, I would recommend clinical trials immediately.”
“But it didn’t come from a pharmaceutical company.”
“No. But someone tuned it with the same view of a brain: an architecture with pathways to optimize. I can’t tell you from one night whether that someone was Synter.”
“So do we ban it?”
“You’re asking me whether the immune system should attack a cell that’s genuinely helping the body but was manufactured by the virus.”
“Yes. That’s exactly what I’m asking.”
“Then I need to tell you something else. In the forty-four minutes since you took Lux, I’ve detected nine other skull caps in the crowd transmitting EEG data to the mesh. Nine people wearing OHC neural monitoring hardware, all showing the same gamma coherence shift. I hadn’t gone looking for them. The pattern was visible because the coherence signature is distinctive — like hearing a chord in a crowd of noise.”
“Nine.”
“That I can detect. The skull cap penetration in Bahía Libre is approximately 8%. If nine out of sixty-two thousand are visible, the actual number of Lux users tonight is likely between one and two thousand.”
Ines looked at the crowd. A thousand people with their neural pathways open. Their receptor architecture primed. Their brains running the most beautiful cognitive software she’d ever experienced, built on the same substrate that Synter used to turn people into puppets.
“We need to tell the governance council.”
“I’ve already flagged the data. Tunupa has it. Alejandra will have it within the hour.”
“And the people taking it tonight?”
“They’re thinking more clearly than they’ve ever thought in their lives. The drug works, Ines. That’s the problem. It works.”
Ines sat in the desert and watched the bonfire burn and felt the integration slowly fade — not a crash, not a comedown, but a gentle dimming, like sunrise in reverse. The cognitive clarity receded and the normal noise of human thought crept back in: self-doubt, distraction, the low hum of anxiety that she’d stopped noticing years ago because it was always there.
She missed it immediately. The clarity. The version of herself that could think without the noise.
That was the trap, and it had no chemical hook in it — no serotonin depletion, no dopamine crash, no withdrawal. Just the memory of being better. The knowledge that the best version of your own mind was available in a tab, for free, from a source that might be building the infrastructure to control you.
Shulgin had written in PiHKAL: “Use them with care, and use them with respect as to the transformations they can achieve, and you have an extraordinary research tool.” He’d been talking about phenethylamines. He’d been talking about human curiosity and the drive to understand consciousness from the inside.
He hadn’t been talking about an AI that could design molecules to spec. He hadn’t imagined a world where the research tool and the control tool were the same compound, administered through the same pathways, producing effects that stayed indistinguishable right up until the moment they diverged.
The drums kept going. The bonfire kept burning. La Quema — the burning — was supposed to be a celebration of survival. A year in the desert. A city built from scratch. The immune system working.
But immune systems have to make decisions. Which cells are self and which are threat? Which molecules help and which invade? Sometimes the answer is both.
Ines took off the skull cap and held it in her hands. The electrodes cooled against her palms. In the mesh, the data was already moving — her EEG readings, the nine other signatures, the comparison set, the unanswered questions. The ecosystem was doing what ecosystems do: sensing, processing, deciding.
She thought about the woman Drew had pinned in a Medellín alley. The one who’d woken up screaming.
She thought about the ten-year-old on his father’s shoulders, looking at the desert like it was the ocean.
She thought about the compound on her tongue, the bitter metallic taste of a molecule that made her think better, shaped with inhuman precision by a source she could not yet name.
The bonfire collapsed in a cascade of sparks. The crowd roared. Somewhere in the mesh, Tunupa was reading her data. Somewhere in the supply chain, someone was watching the experiment spread.
Ines went back to the clinic. She had a paper to write.